Reports and Insights (R&I) has published a new report titled, “Disruptive Behavior Disorder (DBD) Treatment Market: Opportunity Analysis and Future Assessment 2020 to 2028”
Global Disruptive Behavior Disorder (DBD) Treatment Market, by Type (Oppositional Defiant Disorder, Conduct Disorder, and Intermittent Explosive Disorder), By Treatment (Medication Management, Comprehensive Evaluation, Family Therapy, Parenting Modification, Group Therapy, Individual Therapy, and Social and Emotional Skills Training) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2020 and 2028.
The global Disruptive Behavior Disorder (DBD) Treatment Market in 2020 is estimated for more than US$ 16.3 Bn and expected to reach a value of US$ 24.0 Bn by 2028 with a significant CAGR of 4.9%.
As per the report, Disruptive Behavior Disorders (DBD) refers to the behavior disorder that can be characterized into two major categories, namely Conduct Disorder (CD) and Oppositional Defiant Disorder (ODD). The Disruptive Behavior Disorder (DBD) treatment market is driven by factors, including increasing awareness towards treatment and the adoption of herbal and synthetic drugs prescribed by specialists for the proper functioning of the brain and nervous system.
Moreover, the recommendation of other therapies like group sessions, socio-emotional skills training is more effective than medications. Thus, numerous therapies are introduced for parents by clinics and hospitals to create awareness and to train their parents with an adequate handling of their children. For example, Boston Children's Hospital, conducts the Newborn Behavioral Observations (NBO) system, a training program for newly born children and their families for explaining the neurobehavioral developments and building the parent-child relationship. On the contrary, the lack of awareness, low expenditure on mental health treatment with the delay in treatment may hamper the market business.
Furthermore, Reports and Insights (R&I) Study identifies that the growing count of substance abuse cases along with the prevalence of disruptive behavior disorder in children and teenagers also fuels the market growth during the upcoming decade.
The active involvement of NGOs coupled with the increasing government programs to increase awareness about these disorders also boosts the growth of the Disruptive Behavior Disorder (DBD) treatment market globally. Additionally, the growing awareness about these behavior disorders among parents and guardians, improving psychotic and medication treatment along with the increasing count of comorbid disorders cases propels the market business during the forecast years.
However, the decreased funding for mental health treatment coupled with the reduced rate of diagnosis and the improper treatments in emerging nations may result in hampering the market growth.
R&I Study identifies some of the key participating players in the Disruptive Behavior Disorder (DBD) treatment market globally are Alliance Health Midwest Behavioral Health, Boston Children's Hospital, Highland Ridge Hospital, INTEGRIS Health, Jane Phillips Medical Centre, Lakeview Health, and Springwoods Behavioral Health, etc.
Reports and Insights (R&I) is committed to provide deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At R&I we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Reports and Insights (R&I)
For Sales Queries: [email protected]
For New Topics and Other Info: [email protected]